What does Dr. Joachim Demyttenaere do?

Dr. Joachim Demyttenaere is a specialist medical practice in Overijse. Private Limited, started on 1 October 2021, 1 establishment.

What is the address of Dr. Joachim Demyttenaere?

The registered office of Dr. Joachim Demyttenaere is located at Marcel Coppijnlaan 23, 3090 Overijse.

Is Dr. Joachim Demyttenaere still active?

Yes. According to the CBE (29 October 2026) Dr. Joachim Demyttenaere is active, legal situation “Normale toestand”, started on 1 October 2021.

Is Dr. Joachim Demyttenaere registered on Peppol?

Yes, Dr. Joachim Demyttenaere is registered on the Peppol network with ID 0208:0774939136.

What is the enterprise number of Dr. Joachim Demyttenaere?

The enterprise number of Dr. Joachim Demyttenaere is BE0774939136.

When was Dr. Joachim Demyttenaere founded?

Dr. Joachim Demyttenaere was founded on 1 October 2021.

Is Dr. Joachim Demyttenaere a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 October 2021; 4 annual accounts filed, latest fiscal year 2025.

How much profit did Dr. Joachim Demyttenaere make in 2025?

Dr. Joachim Demyttenaere posted a profit after taxes of € 207,598 in financial year 2025.

What is the revenue of Dr. Joachim Demyttenaere?

As a small company, Dr. Joachim Demyttenaere is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 272,066.

Dr. Joachim Demyttenaere (Private Limited) - Overijse

Dossier Dr. Joachim Demyttenaere, printed on 29 October 2026 from databakkes.be/en/0774939136/dr-joachim-demyttenaere. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Joachim Demyttenaere from Overijse, company number BE0774939136, closed financial year 2025 with a result of € 207,598 after tax. For that financial year Dr. Joachim Demyttenaere recorded a gross margin of € 272,066 and equity of € 217,598. Compared with financial year 2024, the result moved from € 158,833 to € 207,598. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 8, 2026.

What it is worth Healthy

€ 217,598

▼ 27% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 207,598

▲ 31% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 101,723

▼ 50% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 289,641 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 749

▼ 86% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,875

▼ 80% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 15,416 Gross margin 2022: € 15,416 First fiscal year in the series	€ 154,907 Gross margin 2023: € 154,907 ▲ € 139,491 vs 2022 (€ 15,416) Favourable step	€ 206,517 Gross margin 2024: € 206,517 ▲ 33% vs 2023 (€ 154,907) Favourable step	€ 272,066 Gross margin 2025: € 272,066 ▲ 32% vs 2024 (€ 206,517) Favourable step	▲ 32%
Profit after taxes	€ 10,237 Profit after taxes 2022: € 10,237 First fiscal year in the series	€ 120,572 Profit after taxes 2023: € 120,572 ▲ € 110,335 vs 2022 (€ 10,237) Favourable step	€ 158,833 Profit after taxes 2024: € 158,833 ▲ 32% vs 2023 (€ 120,572) Favourable step	€ 207,598 Profit after taxes 2025: € 207,598 ▲ 31% vs 2024 (€ 158,833) Favourable step	▲ 31%
Equity	€ 20,237 Equity 2022: € 20,237 First fiscal year in the series	€ 140,808 Equity 2023: € 140,808 ▲ € 120,572 vs 2022 (€ 20,237) Favourable step	€ 299,641 Equity 2024: € 299,641 ▲ 113% vs 2023 (€ 140,808) Favourable step	€ 217,598 Equity 2025: € 217,598 ▼ 27% vs 2024 (€ 299,641) Unfavourable step	▼ 27%
Total debts	€ 13,795 Total debts 2022: € 13,795 First fiscal year in the series	€ 24,418 Total debts 2023: € 24,418 ▲ 77% vs 2022 (€ 13,795) Unfavourable step	€ 22,234 Total debts 2024: € 22,234 ▼ 9% vs 2023 (€ 24,418) Favourable step	€ 7,482 Total debts 2025: € 7,482 ▼ 66% vs 2024 (€ 22,234) Favourable step	▼ 66%
Cash	€ 16,032 Cash 2022: € 16,032 First fiscal year in the series	€ 83,753 Cash 2023: € 83,753 ▲ € 67,721 vs 2022 (€ 16,032) Favourable step	€ 203,875 Cash 2024: € 203,875 ▲ 143% vs 2023 (€ 83,753) Favourable step	€ 101,723 Cash 2025: € 101,723 ▼ 50% vs 2024 (€ 203,875) Unfavourable step	▼ 50%
Retained profit	€ 10,237 Retained profit 2022: € 10,237 First fiscal year in the series	€ 130,808 Retained profit 2023: € 130,808 ▲ € 120,572 vs 2022 (€ 10,237) Favourable step	€ 289,641 Retained profit 2024: € 289,641 ▲ 121% vs 2023 (€ 130,808) Favourable step	€ 207,598 Retained profit 2025: € 207,598 ▼ 28% vs 2024 (€ 289,641) Unfavourable step	▼ 28%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 289,641 Dividend 2025: € 289,641 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 61 Bank debt 2024: € 61 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 61) Favourable step	▼ 100%
Balance sheet total	€ 34,032 Balance sheet total 2022: € 34,032 First fiscal year in the series	€ 165,226 Balance sheet total 2023: € 165,226 ▲ € 131,194 vs 2022 (€ 34,032) Unchanged	€ 321,876 Balance sheet total 2024: € 321,876 ▲ 95% vs 2023 (€ 165,226) Unchanged	€ 225,080 Balance sheet total 2025: € 225,080 ▼ 30% vs 2024 (€ 321,876) Unchanged	▼ 30%

Key figures of Dr. Joachim Demyttenaere, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Joachim Demyttenaere?

What happened at Dr. Joachim Demyttenaere in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 8, 2026 New annual accounts for financial year 2025: profit of € 207,598 (▲ 31% vs 2024). Source: NBB ↗
Oct 1, 2021 New establishment in Overijse. KBO
Oct 1, 2021 Start of the company according to the CBE. KBO

In short

From € 10,237 profit in 2022 to € 207,598 profit in 2025.

Paid € 149,878 in corporate taxes since 2022.

Best year ever: 2025, with € 207,598 profit.

Paid out € 289,641 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Marcel Coppijnlaan 23

3090 Overijse

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

COPAJO

MAUPITI

€ 145,002 gross margin · 2025

Dr. Joséphine Behaegel

€ 49,588 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0774.939.136
VAT number: BE 0774.939.136
Registered office: Marcel Coppijnlaan 23, 3090 Overijse
Names & denominations: Dr. Joachim Demyttenaere
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 October 2021
Peppol: Active · Active since 13 Jan 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Joachim Demyttenaere